US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
KRM22 PLC () (KRMCF) 銘柄情報

KRM22 PLC () (KRMCF)

0.44

0.00

(0.00%)

終了 7月4日 5:00AM

KRM22 PLC () (KRMCF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.44

( - )

買値

0.00

売値

0.00

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.44

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 201,994

発行済株式数

59,316,219

配当利回り

PER

-8.89

1 株当たり利益 (EPS)

-0.05

歳入

7.44M

純利益

-2.03M

KRM22 Plc, together with its subsidiaries, engages in the development and sale of risk management software to the financial services industry in the United Kingdom, Europe, the United States, and internationally. The company offers Global Risk Platform, a cloud-based SaaS portal for trading and corp... KRM22 Plc, together with its subsidiaries, engages in the development and sale of risk management software to the financial services industry in the United Kingdom, Europe, the United States, and internationally. The company offers Global Risk Platform, a cloud-based SaaS portal for trading and corporate risk; Limits Manager for maintaining, auditing, and approving trading limits in multiple platforms; and Risk Manager for risk management. It also provides Surveillance Manager for analytics and market surveillance to help capital market firms identify and manage the potential risks of market abuse and operational breaches; and Control Manager to centralize risk framework and deliver insights to facilitate responsive decisions. The company was founded in 2017 and is headquartered in London, the United Kingdom. 詳細を表示

セクター

Finance

業界

Asset Management Services

ウェブサイト

www.krm22.com

本社

London, United Kingdom

設立

2026

KRM22 PLC () is listed in the Finance sector of the その他OTC with ticker KRMCF. The last closing price for KRM22 () was US$0.44. Over the last year, KRM22 () shares have traded in a share price range of US$ 0.00 to US$ 0.00.

KRM22 () currently has 59,316,219 shares in issue. The market capitalisation of KRM22 () is US$26.10 million. KRM22 () has a price to earnings ratio (PE ratio) of -8.89.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

KRMCF - Frequently Asked Questions (FAQ)

What is the current KRM22 PLC () share price?

The current share price of KRM22 PLC () is US$ 0.44

How many KRM22 PLC () shares are in issue?

KRM22 PLC () has 59,316,219 shares in issue

What is the market cap of KRM22 PLC ()?

The market capitalisation of KRM22 PLC () is USD 26.1M

What is the 1 year trading range for KRM22 PLC () share price?

KRM22 PLC () has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of KRM22 PLC ()?

The price to earnings ratio of KRM22 PLC () is -8.89

What is the cash to sales ratio of KRM22 PLC ()?

The cash to sales ratio of KRM22 PLC () is 3.63

What is the registered address of KRM22 PLC ()?

The registered address for KRM22 PLC () is 84-86 King William Street, London, EC4N 7BL

What is the KRM22 PLC () website address?

The website address for KRM22 PLC () is www.krm22.com

Which industry sector does KRM22 PLC () operate in?

KRM22 PLC () operates in the Asset Management Services sector

doccjc

Bring on the decision and approval . Hopefully, that’ll clean up this board .

thundersteel

thundersteel 4分前

Dealing with lich-I need a 5th on the 4th

Happy 4th vyome hotel guests.... You can check out any time you like, you just can never leave

TS

Flip it

Flip it 4分前

MSBT bought last week $16.90 & $16.72

Hopefully that was bottom

Own some BTCI at $34 have to wait to recover the price.meanwhile collecting dividends

Any thoughts on what else to buy in crypto or should I just stick to what I have

Hole shot King

Hole shot King 4分前

only another $4.80 to go then take a rest $XRP

learningcurve2020

learningcurve2020 5分前

Actually a pretty good presentation kudos to Bosch. I see he referenced that other EC analysis that I posted here a week or so ago. We’ll have to wait to see if it stand up to scrutiny. The contemporary survival figures are greater than what he reports. But at least the trial is less nebulous now.

Dr_Vonschellan

Dr_Vonschellan 7分前

Dear AI Data Center Builder(s) in Texas,
You better get real real serious (and quick) about bringing your OWN electricity source to your proposed site in Texas... Governor Greg Abbott won't be helping you anymore.

https://www.newsweek.com/after-backing-ai-boom-why-greg-abbot

KevGee59

KevGee59 9分前

That said this IPD-based PSM analysis is far more complex than probably anyone expected, and in my view the MHRA's review of it will take at least 6 to 9 months. So if NWBO submitted it around March, we're realistically looking at another 4 to 7 months of waiting from here before a decision.

surfer44

surfer44 9分前

Shipping: Wall Street Doesn't Get it | Pankaj Khanna - @HeidmarMaritimeHoldings

NOTE: HMR ticker is n/a. Can't create a board for this stock :-(

https://youtu.be/9LHB66QqMUE

Huggy Bear

Huggy Bear 9分前

Absolutely hilarious.

Is it impossible for you to comprehend that some people absolutely DETEST CON ARTISTS?

You act as if you expect everyone to support this blatant fraud.

What is wrong with you dude?

GoodGuyBill

GoodGuyBill 11分前

I wonder what the naysayers have to say about this?

https://investorshub.advfn.com/uimage/uploads/2026/7/3/osxphnOT_A_DAMN_THING.jpg

kenjiroo

kenjiroo 11分前

According to JM it would happen today .. he probably forgot he is dealing with ST3 It’s a face Realiz doesn’t know ST3 like we know him !!! He shoulda done some more DD … Maybe ask us first how it works !!

MrBobbob

MrBobbob 11分前

If they were going to reject, it would have happened long ago.

konshe

konshe 13分前

Last year Eptivists gain the upper hand on the market , PPS went up 100% after IDE application submitted, but after not approved, PPS gap down more than 100 %.
This year Bashers gain the upper hand on the markets, PPS went down 40% after IDE application submitted, but if it will be approved

badshah

badshah 16分前

This piece of financial wisdom coming from a school teacher😇😇😇 perhaps a lowly worker at a lowly hedge fund preying in slum waters???

Idunno

Idunno 16分前

Speaking of Grapefruits. I wonder if AF will be subpoenaed to give a deposition under oath. ? BTW, I’m not trying to scare anyone. Least of all you. You use too tough words.

my3sons87

my3sons87 18分前

The California court’s favorable claim construction of the ‘268 patent can materially affect the separate Dolby Vision declaratory judgment action, although it does not determine the outcome by itself. Here’s how.
1. It gives InterDigital a stronger starting position.
In patent litigat

gitreal

gitreal 19分前

I wonder what's so hard to understand about "no gold"?

rapz

You need to direct your question to IKABB who posted it. Check the link included in the post.
IKABB Re: None Thursday, October 16, 2025 11:58:36 AM Post# 137628 of 137629

leroy kelly

leroy kelly 22分前

I actually think IKABB's conclusion was reasonable at the time, but I wouldn't read anything more into that minute order than it actually says.

Here's what the order did:

Defendants had until January 16, 2026 to answer or file a motion to dismiss.
VPLM had until

Implanting

Implanting 27分前

Did they talk about co-management in those articles? If they did, I missed it, but I agree with you, that any participation by the Natives in running or being involved in the mine construction would be a big mistake by FMG. They can consult and oversee the proceedings, but more authority than that I

1manband

1manband 28分前

Feds seek lower prison term for $100 million New Jersey deli fraudster — but some reasons why are hidden

https://www.cnbc.com/2026/07/03/new-jersey-deli-stockfraud-sentence-patten.html

Federal prosecutors are recommending a relatively light prison sentence for a man who

CryptoRain

CryptoRain 28分前

Jake731

Jake731 28分前

Who’s crying ?

beartrap12

beartrap12 29分前

DocLogic, you are so right! With about 66 patients receiving DCVax-L that we know of still alive (a few years ago), 33 in the Ph III trial, we should have been approved with little effort. That's because NOTHING has been proven to keep GBM patients alive beyond 5 years. NOTHING!!
In fact, dur

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。